The study found that YTHDF2 expression was notably higher in GC tissues than normal tissues (Wilcoxon test p = 1.2e-07, T-test p = 3.4e-11), indicating its potential effect in the initiation and progression of GC (Figure 6C). The gene discussed is YTHDF2; the disease is gastric cancer.